View More Recent Stories

Dec 23, 2024 08:11AM APLT FRAUD NEWS: Applied Therapeutics, Inc. Investors are Notified of the February 18 Deadline in the Securities Fraud Class Action and are Urged to Contact BFA Law
Dec 23, 2024 05:58AM William Blair Downgrades Applied Therapeutics (APLT) to Market Perform
Dec 22, 2024 10:32PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Purchasers to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Dec 21, 2024 06:40PM ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Applied Therapeutics, Inc. Purchasers to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Dec 21, 2024 07:12AM APLT COURT NOTICE: BFA Law Alerts Applied Therapeutics, Inc. Investors a Securities Fraud Class Action Has Been Filed with a February 18 Court Deadline
Dec 20, 2024 06:39PM ROSEN, GLOBALLY RECOGNIZED INVESTOR RIGHTS COUNSEL, Encourages Applied Therapeutics, Inc. Purchasers to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Dec 20, 2024 04:07PM APLT INVESTOR NOTICE: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Dec 20, 2024 09:23AM Applied Therapeutics (APLT) PT Lowered to $1.50 at RBC Capital Following FDA's Warning Letter
Dec 20, 2024 07:01AM Applied Therapeutics Inc. (APLT) Appoints John H. Johnson as Executive Chairman
Dec 19, 2024 04:00PM APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Dec 18, 2024 08:00PM APLT ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc. Investors
Dec 12, 2024 08:01PM Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Applied Therapeutics, Inc. (APLT)
Dec 2, 2024 06:55AM Applied Therapeutics (APLT) PT Lowered to $5 at Baird
Nov 29, 2024 06:09AM Applied Therapeutics (APLT) PT Lowered to $5 at Baird
Nov 29, 2024 05:28AM Applied Therapeutics Inc. (APLT) call put ratio 1 call to 1.4 puts into receiving CRL from FDA on NDA for govorestat
Nov 29, 2024 05:22AM RBC Capital Downgrades Applied Therapeutics (APLT) to Sector Perform
Nov 27, 2024 04:10PM Applied Therapeutics (APLT) Receives CRL from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia
Nov 27, 2024 04:06PM Applied Therapeutics Inc. (APLT) Halted, News Pending
Oct 7, 2024 06:01AM Leerink Partners Reiterates Outperform Rating on Applied Therapeutics (APLT)
Sep 27, 2024 03:46PM Applied Therapeutics Inc. (APLT) 6800 contracts of January 2.5 puts trade
Sep 19, 2024 06:37AM Baird Reiterates Outperform Rating on Applied Therapeutics (APLT)
Sep 18, 2024 03:29PM Applied Therapeutics Inc. (APLT) October 7.5, October 10 and January 12.50 calls active
Sep 18, 2024 07:02AM Applied Therapeutics (APLT) Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia
Jul 31, 2024 06:02AM William Blair Starts Applied Therapeutics (APLT) at Outperform
Jul 17, 2024 06:41AM RBC Capital Reiterates Outperform Rating on Applied Therapeutics (APLT)
Jul 9, 2024 07:00PM 2Q24 U.S. biotech earnings preview
View More Recent Stories